Geneoscopy, Inc.

About Geneoscopy, Inc.

Geneoscopy is dedicated to transforming gastrointestinal health through innovative, noninvasive diagnostic tests. Their mission is to empower patients and healthcare providers by helping to prevent, detect, and monitor gastrointestinal diseases using advanced molecular technologies.

Products & Services

Colorectal Cancer Screening:A noninvasive, stool-based test designed to enable early detection and prevention of colorectal cancer, addressing barriers to traditional screening methods like colonoscopies.

Inflammatory Bowel Disease Diagnostics:Tests to diagnose and manage conditions such as ulcerative colitis and Crohn's disease using molecular technologies.

Other Gastrointestinal Disease Tests:Solutions for detecting and monitoring various gastrointestinal diseases with a focus on safety, effectiveness, and accessibility.

Specialties

Gastrointestinal Health Colorectal Cancer Screening Inflammatory Bowel Disease Management Noninvasive Diagnostics Molecular Technologies Stool-derived Eukaryotic RNA (seRNA) Technology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series C T: - FT: Series C	A: 105000000 MR: - FA: $105M FAN: 105000000	D: 2025-01-08 FD: 2025-01-08	10 investors

Series C Latest

2025-01-08

$105.0M

10 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

David Lieberman

MD, Board Chair

J

John Carethers

MD, MACP

S

Samir Gupta

MD

F

Folasade May

MD, PhD, MPhil

A

Aasma Shaukat

Professor of Medicine and Gastroenterology

M

Matthew A. Ciorba

MD, Board Chair

View 30 more team members with Pro

Unlock Full Team Directory

Recent News

Geneoscopy, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised